• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大体外观能提示肝内胆管癌的预后吗?

Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?

作者信息

Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M

机构信息

Department of Gastrointestinal Surgery, Institute of Gastroenterology, Tokyo Women's Medical College, Japan.

出版信息

J Surg Oncol. 1998 Nov;69(3):162-7. doi: 10.1002/(sici)1096-9098(199811)69:3<162::aid-jso8>3.0.co;2-l.

DOI:10.1002/(sici)1096-9098(199811)69:3<162::aid-jso8>3.0.co;2-l
PMID:9846503
Abstract

BACKGROUND AND OBJECTIVES

Survival after surgery for intrahepatic cholangiocarcinoma (ICC) is usually poor. The objective of this study was to investigate whether the gross appearance of ICC indicates postoperative prognosis.

METHODS

Seventy patients with ICC underwent hepatectomy, with a 50% curative resection rate. Tumors were classified according to gross appearance [mass-forming (n=28), periductal-infiltrating (n=14), intraductal growth (n=10), and mass-forming plus periductal-infiltrating (n=18)], and the presence of lymph node or intrahepatic metastasis was studied microscopically.

RESULTS

The incidence of positive lymph nodes was significantly higher in the patients with mass-forming plus periductal-infiltrating tumors than in those with intraductal growth tumors (P=0.0089). The curative resection rate was significantly lower in patients with mass-forming plus periductal-infiltrating tumors than in those with either mass-forming or intraductal growth tumors (P=0.0001, P=0.0048, respectively). The 5-year survival rate after surgery in patients with mass-forming plus peri-ductal-infiltrating tumors (0%) was significantly lower than that in patients with mass-forming tumors (39%) or intraductal growth tumors (69%) (P=0.0036, P=0.0011, respectively). Multivariate analysis using Cox's hazards model revealed that lymph node metastasis (P=0.0109) and curative resection (P=0.0315) were statistically significant independent prognostic factors; however, macroscopic types were not.

CONCLUSIONS

Patients with mass-forming plus periductal-infiltrating ICCs have a poor prognosis; however, the macroscopic types may not be a statistically significant independent prognostic factor.

摘要

背景与目的

肝内胆管癌(ICC)手术后的生存率通常较低。本研究的目的是探讨ICC的大体外观是否能提示术后预后。

方法

70例ICC患者接受了肝切除术,根治性切除率为50%。根据大体外观对肿瘤进行分类[肿块型(n = 28)、胆管周围浸润型(n = 14)、管内生长型(n = 10)和肿块型加胆管周围浸润型(n = 18)],并通过显微镜检查研究淋巴结或肝内转移的情况。

结果

肿块型加胆管周围浸润型肿瘤患者的阳性淋巴结发生率显著高于管内生长型肿瘤患者(P = 0.0089)。肿块型加胆管周围浸润型肿瘤患者的根治性切除率显著低于肿块型或管内生长型肿瘤患者(分别为P = 0.0001,P = 0.0048)。肿块型加胆管周围浸润型肿瘤患者术后的5年生存率(0%)显著低于肿块型肿瘤患者(39%)或管内生长型肿瘤患者(69%)(分别为P = 0.0036,P = 0.0011)。使用Cox风险模型进行多因素分析显示,淋巴结转移(P = 0.0109)和根治性切除(P = 0.0315)是具有统计学意义的独立预后因素;然而,大体类型并非如此。

结论

肿块型加胆管周围浸润型ICC患者预后较差;然而,大体类型可能不是具有统计学意义的独立预后因素。

相似文献

1
Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?大体外观能提示肝内胆管癌的预后吗?
J Surg Oncol. 1998 Nov;69(3):162-7. doi: 10.1002/(sici)1096-9098(199811)69:3<162::aid-jso8>3.0.co;2-l.
2
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.
3
Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.肝内胆管癌的大体类型:临床病理特征及手术结果
Hepatogastroenterology. 2002 Mar-Apr;49(44):326-9.
4
Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.肿块形成加肝内胆管癌导管周围浸润型的手术结果:与典型肿块形成型肝内胆管癌的比较研究
World J Surg. 2007 Oct;31(10):2016-22. doi: 10.1007/s00268-007-9194-0.
5
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.肝内胆管癌的外科治疗结果及影响生存的临床病理因素
Br J Surg. 2002 Dec;89(12):1525-31. doi: 10.1046/j.1365-2168.2002.02268.x.
6
Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.肝切除术后肝内胆管癌的预后因素:单因素和多因素分析
Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6.
7
Recurrence after surgical resection of intrahepatic cholangiocarcinoma.肝内胆管癌手术切除后的复发
J Hepatobiliary Pancreat Surg. 2001;8(2):154-7. doi: 10.1007/s005340170039.
8
Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan.日本肝内胆管癌肝切除的临床病理特征及预后
J Hepatobiliary Pancreat Surg. 1999;6(2):108-16. doi: 10.1007/s005340050092.
9
Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.肝内胆管癌术后肝脏复发的预测因素
J Gastroenterol. 2006 Sep;41(9):893-900. doi: 10.1007/s00535-006-1877-z.
10
Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.肝内胆管癌的肝切除术:与大体肿瘤形态的关系
Hepatogastroenterology. 2001 Jul-Aug;48(40):1129-33.

引用本文的文献

1
Management of intrahepatic cholangiocarcinoma: a review for clinicians.肝内胆管癌的管理:临床医生综述
Gastroenterol Rep (Oxf). 2025 Jan 26;13:goaf005. doi: 10.1093/gastro/goaf005. eCollection 2025.
2
Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review.世界卫生组织肝内胆管癌亚型分类的外科解读:一篇综述
Surg Today. 2025 Jan;55(1):1-9. doi: 10.1007/s00595-024-02825-x. Epub 2024 Apr 2.
3
Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report.
最初诊断为不明原发腺癌伴肝十二指肠韧带淋巴结转移的肝内胆管癌:一例报告。
Oncol Lett. 2023 Nov 8;27(1):7. doi: 10.3892/ol.2023.14140. eCollection 2024 Jan.
4
Pathology of Cholangiocarcinoma.胆管癌病理学。
Recent Results Cancer Res. 2023;219:91-107. doi: 10.1007/978-3-031-35166-2_5.
5
Intrahepatic cholangiocarcinoma in patients with primary sclerosing cholangitis and ulcerative colitis: Two case reports.原发性硬化性胆管炎和溃疡性结肠炎患者的肝内胆管癌:两例病例报告。
World J Gastrointest Surg. 2023 Jun 27;15(6):1224-1231. doi: 10.4240/wjgs.v15.i6.1224.
6
Radiological Shape of the Tumor Predicts Progression and Survival in Resected Extrahepatic Cholangiocarcinoma.肿瘤的放射学形态可预测肝外胆管癌切除术后的进展和生存。
J Gastrointest Surg. 2023 Jun;27(6):1113-1121. doi: 10.1007/s11605-023-05614-y. Epub 2023 Feb 7.
7
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.日本肝癌研究组肝内胆管癌临床实践指南
Liver Cancer. 2022 Feb 23;11(4):290-314. doi: 10.1159/000522403. eCollection 2022 Jul.
8
Intrahepatic Cholangiocarcinoma With Neither Intrahepatic Metastasis Nor Lymph Node Metastasis Is the Optimal Indication for Hepatectomy With Adjuvant Therapy.既无肝内转移也无淋巴结转移的肝内胆管癌是肝切除联合辅助治疗的最佳适应证。
Cancer Diagn Progn. 2022 Mar 3;2(2):160-166. doi: 10.21873/cdp.10090. eCollection 2022 Mar-Apr.
9
Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma.炎症生物标志物与肿块型肝内胆管细胞癌根治性手术后长期结局的相关性。
Surg Today. 2020 Apr;50(4):379-388. doi: 10.1007/s00595-019-01905-7. Epub 2019 Oct 30.
10
The Evaluation of the Eighth Edition of the AJCC/UICC Staging System for Intrahepatic Cholangiocarcinoma: a Proposal of a Modified New Staging System.第八版 AJCC/UICC 肝内胆管癌分期系统的评估:一个改良的新分期系统的建议。
J Gastrointest Surg. 2020 Apr;24(4):786-795. doi: 10.1007/s11605-019-04185-1. Epub 2019 Apr 22.